Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

The diagnostic landscape of non-small cell lung cancer (NSCLC) is changing rapidly with the availability of novel treatments. Despite high-level healthcare in the Netherlands, not all patients with NSCLC are tested with the currently relevant predictive tumor markers that are necessary for optimal d...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Broek, Daan, Hiltermann, T. Jeroen N., Biesma, Bonne, Dinjens, Winand N. M., 't Hart, Nils A., Hinrichs, John W. J., Leers, Mathie P. G., Monkhorst, Kim, van Oosterhout, Matthijs, Scharnhorst, Volkher, Schuuring, Ed, Speel, Ernst-Jan M., van den Heuvel, Michel M., van Schaik, Ron H. N., von der Thüsen, Jan, Willems, Stefan M., de Visser, Leonie, Ligtenberg, Marjolijn J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987414/
https://www.ncbi.nlm.nih.gov/pubmed/32039011
http://dx.doi.org/10.3389/fonc.2019.01521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987414/
https://www.ncbi.nlm.nih.gov/pubmed/32039011
http://dx.doi.org/10.3389/fonc.2019.01521

Ejemplares similares